Kestra Medical Technologies, Ltd. (KMTS) stock
KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
$28.29+0.02 (+0.07%)
Close on Nov 18, 2026Market cap $1.69BP/E –Yield –
Kestra Medical Technologies operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Kestra Medical Technologies's operating income for the twelve months ending Jul 31, 2026 was -$143.52M. For fiscal 2026 it was -$134.74M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | -$134.74M | – |
| FY2025 | Apr 30, 2025 | -$106.38M | – |
| FY2024 | Apr 30, 2024 | -$85.06M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | -$37.66M | – |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | -$39.34M | – |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | -$34.77M | – |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | -$31.76M | – |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | -$28.88M | – |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | -$48.21M | – |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | -$20.60M | – |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | -$19.13M | – |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | -$18.43M | – |
See a number that looks wrong?